GERN Stock Analysis: Buy, Sell, or Hold?
GERN - Geron Corp
$1.51
-0.03 (-1.95%)
▼
5d:
+9.42%
30d:
+14.39%
90d:
+19.84%
HOLD
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Feb 25, 2026
21d
Get Alerted When GERN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called GERN this week
50% bullish • 1 bearish
50% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GERN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GERN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GERN is currently trading at $1.51, which is considered extended relative to its 30-day fair value range of $1.31 to $1.42.
Technical Outlook: Technically, GERN is in a downtrend. Immediate support is located at $1.29, while resistance sits at $1.58.
Market Sentiment: GERN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.40 (+125.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GERN is in a downtrend. Immediate support is located at $1.29, while resistance sits at $1.58.
Market Sentiment: GERN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.40 (+125.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.31 -
$1.42
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+6.3% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 125.2% below Wall St target ($3.40)
Fair Price Analysis
30-Day Fair Range
$1.31 -
$1.42
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.29
Resistance Level
$1.58
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-60.40
Wall Street Target
$3.40
(+125.2%)
Revenue Growth (YoY)
67.1%
Profit Margin
-43.6%
Last updated: February 03, 2026 4:39 PM ET
Data refreshes hourly during market hours. Next update: 5:39 PM
Data refreshes hourly during market hours. Next update: 5:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GERN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 59 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 57 HOLD |
